Ning Li

机构：Peking University, University of South China · ORCID：0000-0002-8388-5080

发表论文 191 篇 · 总被引 3047 次 · h-index 30

代表论文

• Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial (2025 · The Lancet · 被引 131)
• First-in-class PD-1/IL-2 bispecific antibody IBI363 in patients (Pts) with advanced immunotherapy-treated non-small cell lung cancer (NSCLC). (2025 · Journal of Clinical Oncology · 被引 14)
• Transforming the landscape of cancer treatment with seven promising novel therapies: evolution and future perspectives (2025 · Medicine Plus · 被引 14)
• YOLO-feed: An advanced lightweight network enabling real-time, high-precision detection of feed pellets on CPU devices and its applications in quantifying individual fish feed intake (2025 · Aquaculture · 被引 13)
• Reactive-extractive distillation processes design for aqueous ternary azeotrope separation (2025 · Applied Thermal Engineering · 被引 6)
• Immunocyte-derived extracellular vesicles in osteoimmunology: mechanisms, disease contexts, and translational prospects (2025 · Frontiers in Immunology · 被引 5)